---
title: "12 Health Care Stocks Moving In Friday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299475827.md"
description: "During Friday's intraday session, several healthcare stocks experienced significant volatility. Gainers included IM Cannabis (up 246%), SkyAI (+20.43%), and BioStem Technologies (+19.52%). Conversely, major losers featured Xenon Pharmaceuticals (-30.2%), Alaunos Therapeutics (-28.13%), and Nuwellis (-18.5%). The report highlights specific price movements and market capitalizations for these listed companies."
datetime: "2026-09-18T17:05:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299475827.md)
  - [en](https://longbridge.com/en/news/299475827.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299475827.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's Intraday Session

### Gainers

-   **IM Cannabis** (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular session. The market value of their outstanding shares is at $1.0 million.
-   **SkyAI** (NASDAQ:SKYA) stock rose 20.43% to $1.65. The company's market cap stands at $59.2 million.
-   **BioStem Technologies** (NASDAQ:BSEM) stock increased by 19.52% to $5.21. The company's market cap stands at $77.7 million.
-   **Solana** (NASDAQ:HSDT) stock moved upwards by 18.34% to $2.71. The company's market cap stands at $138.4 million.
-   **XORTX Therapeutics** (NASDAQ:XRTX) shares increased by 17.33% to $1.95. The market value of their outstanding shares is at $3.0 million.
-   **bioAffinity Technologies** (NASDAQ:BIAF) shares increased by 15.2% to $10.08. The company's market cap stands at $5.2 million.

### Losers

-   **Xenon Pharmaceuticals** (NASDAQ:XENE) shares declined by 30.2% to $40.01 during Friday's regular session. The company's market cap stands at $5.5 billion.
-   **Alaunos Therapeutics** (NASDAQ:TCRT) stock fell 28.13% to $1.15. The company's market cap stands at $4.0 million.
-   **Nuwellis** (NASDAQ:NUWE) stock decreased by 18.5% to $0.89. The market value of their outstanding shares is at $3.4 million.
-   **DataMEDS AI** (NASDAQ:MEDS) shares decreased by 17.08% to $3.85. The market value of their outstanding shares is at $14.8 million.
-   **Korro Bio** (NASDAQ:KRRO) stock fell 14.92% to $10.04. The market value of their outstanding shares is at $173.7 million.
-   **Longeveron** (NASDAQ:LGVN) stock fell 12.74% to $2.37. The company's market cap stands at $8.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)
- [XENE.US](https://longbridge.com/en/quote/XENE.US.md)
- [BSEM.US](https://longbridge.com/en/quote/BSEM.US.md)
- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)
- [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md)
- [SKYA.US](https://longbridge.com/en/quote/SKYA.US.md)
- [HSDT.US](https://longbridge.com/en/quote/HSDT.US.md)
- [XRTX.US](https://longbridge.com/en/quote/XRTX.US.md)
- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)
- [MEDS.US](https://longbridge.com/en/quote/MEDS.US.md)
- [KRRO.US](https://longbridge.com/en/quote/KRRO.US.md)
- [LGVN.US](https://longbridge.com/en/quote/LGVN.US.md)
- [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md)

## Related News & Research

- [IM Cannabis Stock Falls after $1.31 Million Offering Follows Drone Deal](https://longbridge.com/en/news/299915374.md)
- [Xenon Pharmaceuticals (XENE) Could Be 47% Undervalued Following Psychiatry Trial Pause](https://longbridge.com/en/news/299566976.md)
- [Xenon Pharmaceuticals Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Xenon Pharmaceuticals (XENE)](https://longbridge.com/en/news/299818011.md)
- [Alaunos Therapeutics Announces New Registered Direct Offering](https://longbridge.com/en/news/299813835.md)
- [Alaunos Therapeutics Enters Securities Purchase Agreement With Accredited Investors](https://longbridge.com/en/news/299810727.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**